Literature DB >> 17087853

Benefits of renin-angiotensin system blockade in advanced renal insufficiency.

Simardeep Mangat, Steven A Atlas.   

Abstract

Entities:  

Year:  2006        PMID： 17087853     DOI： 10.1007/s11906-006-0020-0

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN： 1522-6417            Impact factor:   5.369


× No keyword cloud information.
  12 in total

1.  Coadministration of losartan and enalapril exerts additive antiproteinuric effect in IgA nephropathy.

Authors:  D Russo; R Minutolo; A Pisani; R Esposito; G Signoriello; M Andreucci; M M Balletta
Journal:  Am J Kidney Dis       Date:  2001-07       Impact factor: 8.860

2.  ACE inhibitors to prevent end-stage renal disease: when to start and why possibly never to stop: a post hoc analysis of the REIN trial results. Ramipril Efficacy in Nephropathy.

Authors:  Piero Ruggenenti; Annalisa Perna; Giuseppe Remuzzi
Journal:  J Am Soc Nephrol       Date:  2001-12       Impact factor: 10.121

3.  Safety of the combination of valsartan and benazepril in patients with chronic renal disease. European Group for the Investigation of Valsartan in Chronic Renal Disease.

Authors:  L M Ruilope; J C Aldigier; C Ponticelli; P Oddou-Stock; F Botteri; J F Mann
Journal:  J Hypertens       Date:  2000-01       Impact factor: 4.844

4.  Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study.

Authors:  C E Mogensen; S Neldam; I Tikkanen; S Oren; R Viskoper; R W Watts; M E Cooper
Journal:  BMJ       Date:  2000-12-09

5.  Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern?

Authors:  G L Bakris; M R Weir
Journal:  Arch Intern Med       Date:  2000-03-13

6.  Efficacy and safety of benazepril for advanced chronic renal insufficiency.

Authors:  Fan Fan Hou; Xun Zhang; Guo Hua Zhang; Di Xie; Ping Yan Chen; Wei Ru Zhang; Jian Ping Jiang; Min Liang; Guo Bao Wang; Zheng Rong Liu; Ren Wen Geng
Journal:  N Engl J Med       Date:  2006-01-12       Impact factor: 91.245

7.  Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial.

Authors:  Naoyuki Nakao; Ashio Yoshimura; Hiroyuki Morita; Masyuki Takada; Tsuguo Kayano; Terukuni Ideura
Journal:  Lancet       Date:  2003-01-11       Impact factor: 79.321

8.  Add-on angiotensin receptor blocker in patients who have proteinuric chronic kidney diseases and are treated with angiotensin-converting enzyme inhibitors.

Authors:  Yoshihiko Kanno; Tsuneo Takenaka; Tsukasa Nakamura; Hiromichi Suzuki
Journal:  Clin J Am Soc Nephrol       Date:  2006-05-17       Impact factor: 8.237

9.  Effects of combined ACE inhibitor and angiotensin II antagonist treatment in human chronic nephropathies.

Authors:  Ruth Campbell; Fabio Sangalli; Elena Perticucci; Claudio Aros; Cecilia Viscarra; Annalisa Perna; Andrea Remuzzi; Federico Bertocchi; Luca Fagiani; Giuseppe Remuzzi; Piero Ruggenenti
Journal:  Kidney Int       Date:  2003-03       Impact factor: 10.612

Review 10.  Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis.

Authors:  Juan P Casas; Weiliang Chua; Stavros Loukogeorgakis; Patrick Vallance; Liam Smeeth; Aroon D Hingorani; Raymond J MacAllister
Journal:  Lancet       Date:  2005-12-10       Impact factor: 79.321
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.